Tools

A major trial of a new booster vaccine has ended in failure, marking a major setback in the fight against… »   

Biotechnology company Gilead Sciences on Monday said two trials of its hepatitis C drug, the centerpiece of its oral hepatitis… »   

Hemispherx Biopharma Inc said U.S. regulators had declined to approve its new drug application for Ampligen, its experimental drug for… »   

With the discovery of antibiotics, medicine acquired power on a scale never before possible to protect health, save lives, and… »   

Worldwide, many strains of the bacterium Staphyloccocus aureus are already resistant to all antibiotics except vancomycin. But as bacteria are… »   

New data suggests the erectile dysfunction (ED) drug Cialis may also be beneficial in helping men who have problems… »   

Researchers at Moffitt Cancer Center and colleagues have investigated the safety, efficacy and the maximum tolerated dose of pomalidomide for… »   

Eli Lilly and Co’s stomach cancer drug ramucirumab met its primary goal of improving overall survival in a late stage-study,… »   

Johnson & Johnson may sell or spin off its slow-growing $2 billion-a-year diagnostics business, the company said on Tuesday when… »   

Novartis expects sales to grow in the mid-single digits from 2014 once it has absorbed the full impact of competition… »